ARCHIVES

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 32 | August 13, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program

July 30, 1982

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004